WebbCystic fibrosis (CF) diagnostic microbiology has evolved from a focus on Staphylococcus aureus as primary pathogen to identification of the contribution of Pseudomonas … WebbSummary. Cystic fibrosis (CF) is a single gene recessive disorder that affects ∼70,000 individuals worldwide. Median survival for individuals with CF has progressively …
Page Title Cystic Fibrosis Foundation
WebbMayer-Hamblett, Nicole ; Nichols, David P. ; Odem-Davis, Katherine et al. / Evaluating the impact of stopping chronic therapies after modulator drug therapy in cystic fibrosis : The SIMPLIFY clinical trial study design. In: Annals of the American Thoracic Society. 2024 ; Vol. 18, No. 8. pp. 1397-1405. Webb9 nov. 2024 · The journey to end cystic fibrosis isn't a straight line. It is an evolving map with many paths and unique challenges. It requires an ambitious research agenda to accelerate treatments and drug development for the underlying cause of the disease and ultimately deliver a cure. fmb-1101
Annals of the American Thoracic Society - ATS Journals
WebbMethods: The SIMPLIFY study included two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials at 80 participating clinics across the USA in the Cystic … WebbHighly effective CFTR modulator drug therapy is increasingly available to those with cystic fibrosis. Multiple observational research studies are now being conducted to better understand the impacts of this important therapeutic milestone on long-term outcomes, patient care needs, and future research priorities. WebbThe mutated gene that causes cystic fibrosis affects a protein that helps with salt regulation across cells. In addition to losing more salt through sweat than is normal, the mutation affects how salt and water move through channels in the body, leading to changes in mucus. (Parents of babies with cystic fibrosis often notice, when kissing ... greensboro milb team